drugset / Trial / NCT01045317

A Study To Investigate The Clearance Of PF-04776548 From The Body Following A Very Low (Micro) Dose Of The Compound Using A Low Level Of Radiotracer To Help Quantify Expected Low Concentrations Of PF-04776548 In The Body

NCT01045317 ↗

Phase 1 Completed 10 enrolled Pfizer
RandomizedParallel-groupOpen-labelBasic science

Summary

To investigate the pharmacokinetics of PF-04776548 following administration of a micro-dose of PF-04776548 via both intravenous and oral routes.

Timeline

Start
2010-01
Primary completion
2010-02
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-04776548 Small molecule 0.1 mg Intravenous